Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topical "soft" JAK 1/3 inhibitor, in patients with mild to
Presenter SpeechLut Ming Cheng Good afternoon. Thanks for joining us for another session at the 42nd JPMorgan Healthcare Conference. I m Brian Cheng. I m one of the senior biotech analysts here at the.
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) and Roivant Sciences (NASDAQ:ROIV – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends. Earnings & Valuation This table compares Oncolytics Biotech […]
Roivant Sciences: Why Its Vant Biotech Model Is A Buy (NASDAQ:ROIV) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.